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Macrophages represent the primary human host response to pathogen infection and
link the immediate defense to the adaptive immune system. Mature tissue macrophages
convert from circulating monocyte precursor cells by terminal differentiation in a process
that is not fully understood. Here, we analyzed the protein kinases of the human
monocytic cell line THP-1 before and after induction of macrophage differentiation by
using kinomics and phosphoproteomics. When comparing the macrophage-like state
with the monocytic precursor, 50% of the kinome was altered in expression and even
71% of covered kinase phosphorylation sites were affected. Kinome rearrangements
are for example characterized by a shift of overrepresented cyclin-dependent
kinases associated with cell cycle control in monocytes to calmodulin-dependent
kinases and kinases involved in proinflammatory signaling. Eventually, we show
that monocyte-to-macrophage differentiation is associated with major rewiring of
mitogen-activated protein kinase signaling networks and demonstrate that protein kinase
MAP3K7 (TAK1) acts as the key signaling hub in bacterial killing, chemokine production
and differentiation. Our study proves the fundamental role of protein kinases and cellular
signaling as major drivers of macrophage differentiation and function. The finding that
MAP3K7 is central to macrophage function suggests MAP3K7 and its networking
partners as promising targets in host-directed therapy for macrophage-associated
disease.
Keywords: chemical proteomics, kinomics, phosphoproteome, monocyte-to-macrophage differentiation, kinome,
signaling, THP-1 cells
INTRODUCTION
Cellular differentiation is a fundamental process in development that is triggered by internal
or external stimuli resulting in cells with increased degree of specialization with regard to
its respective progenitors. On the molecular level cell transformation is founded on signaling
Abbreviations: 5Z, (5Z)-7-Oxozeaenol; CFU, colony forming units; ELISA, enzyme linked immunosorbent assay; GFP, green
fluorescent protein; IPA, Ingenuity pathway analysis; KEGG, Kyoto Encyclopedia of Genes and Genomes; MAPK, mitogen
activated protein kinase; MPS, mononuclear phagocyte system; PMA, phorbol-12-myristate 13-acetate; SILAC, stable isotope
labeling by amino acids in cell culture; SMAC, small molecule affinity chromatography; TAK1, Transforming growth factor
β-activated kinase; LC-MS/MS, Liquid chromatography–mass spectrometry.
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networks that transduce stimuli from the cell surface to
modulators by protein phosphorylation and dephosphorylation
as the most important posttranslational modification in
transmission and integration of signals in cellular networks.
The mononuclear phagocyte system (MPS) represents an
impressive example of how cell differentiation generates
functional and phenotypic diversity. The common origin of
cells of the MPS are hematopoietic stem cells located in
the bone marrow that transform through different myeloid
progenitor intermediates to monocytes that enter circulation,
migrate into tissue and terminally differentiate to replenish
resident dendritic cells and macrophages (Geissmann et al.,
2010a). Macrophages differ from their monocytic precursors
morphologically and are characterized by elevated lysosomal
and mitochondrial content as well as in their responsiveness to
pathogen-associated molecular patterns—small molecular motifs
conserved within a class of microbes (Cohn, 1968; Ross and
Auger, 2002). Furthermore, monocytes and macrophages are
both critical effectors and regulators of inflammation and the
innate immune response e.g., by producing growth factors and
cytokines (Geissmann et al., 2010b). The differential degree of
functional specialization and adaptive capabilities are attributable
to molecular structures that are significantly co-determined by
cell signaling components.We hypothesize that major differences
exist between the kinomes of monocytes and macrophages and
that this has a determining influence in shaping the functional
cellular characteristics. Comparative profiling of the kinomes of
both cell types could thus increase our understanding in the
signal transduction capabilities and assist identification of kinases
that are associated with cell type-specific functions.
Analysis of monocyte function and differentiation is
still a challenging task. Monocytes permanently sense their
environment and react with rapid alteration in phenotype and
behavior already during isolation and processing (Auffray et al.,
2009). Moreover, limited quantities and heterogeneity of the
monocyte population in terms of differentiation stages hinder
their analysis. To overcome these drawbacks, a number of
human leukemia model cell lines with monocytic characteristics
have been established that represent a relative homogenous
population and can easily be expanded in vitro. These cell lines
are blocked at different stages of differentiation but can be
released for further progression using specific stimuli (Auwerx,
1991). The human cell line THP-1 is one of the most frequently
used model system with monocytic properties (Tsuchiya et al.,
1980). THP-1 cells can be differentiated into macrophage-
like cells that resemble properties of mature macrophages by
activation of protein kinase C (PKC) with phorbol-12-myristate-
13-acetate (PMA), ultimately resulting in cells with increased
adherence and loss of proliferative activity (Schwende et al.,
1996).
Several recent studies employed proteomic techniques that
revealed changes in the proteome signature that are associated
with differentiation of monocytes to macrophages. Accordingly,
increased expression of proteins involved in the suppression
of NF-κB including superoxide dismutase 2 (SOD2), the
sodium pump subunit alpha-1 (ATP1A1) and a serine peptidase
inhibitor (SERPINB2) was highlighted during differentiation
of primary human monocytes (Kraft-Terry and Gendelman,
2011). In addition, PMA-induced differentiation of U937 cells
is associated with elevated expression of proteins involved in
carbohydrate metabolism, antioxidant defense and actin filament
rearrangement (Sintiprungrat et al., 2010). Although, these
studies shed light on the functional rearrangement on the
proteome level, cellular signaling nodes including kinases and
phosphatases as the driving forces behind cellular differentiation
are underrepresented and hence their impact on monocyte and
macrophage properties is not well understood.
Here, we applied a quantitative chemical proteomics strategy
for the systematic analysis of the kinome following PMA-
triggered differentiation of THP-1 monocytes. We reveal major
kinome rearrangement following monocyte differentiation
and demonstrate that the macrophage-associated kinase
MAP3K7/TAK1 is a central hub in the signal transduction
involved in bacterial killing, chemokine production and the
differentiation process itself.
MATERIALS AND METHODS
Cell Culture, SILAC, and Differentiation
THP-1monocytes were purchased from the German collection of
microorganisms and cell cultures (DSMZ). Stable isotope labeling
with amino acids in cell culture (SILAC, Ong et al., 2002, 2003)
was achieved by propagating cells in RPMI 1640 free of L-lysine,
L-arginine and L-glutamine (PAA Laboratories) supplemented
with 220 µM L-lysine and 144 µM L-arginine in either their
light (Lys-0 and Arg-0) or heavy isotope-labeled forms (13C156 N2-
L-lysine/Lys-8 and 13C156 N4-L-arginine/Arg-10) (Silantes), 2mM
L-glutamine (Sigma-Aldrich), 10% heat-inactivated dialyzed fetal
calf serum (FCS) (Sigma-Aldrich) and the antibiotics penicillin
and streptomycin (Biochrom) at concentrations of 100 units/ml
and 100 µg/ml respectively. Cell culturing was performed at
37◦C and 5% CO2 in a humidified atmosphere. Cells were
grown for at least six cell doublings to ensure complete
incorporation of labeled amino acids. For differentiation,
phorbol-12-myristate 13-acetate (PMA) (Sigma-Aldrich) was
added to a final concentration of 100 nM. After 3 days, the PMA
supplemented media was removed, cells were washed with PBS
and rested in fresh PMA-free media for further 24 h in order
to obtain phenotypic characteristics of macrophages (Daigneault
et al., 2010).
Immobilization of Kinase Inhibitors
Affinity beads were prepared with modifications as described
elsewhere (Bantscheff et al., 2007; Wissing et al., 2007).
Carbodiimid chemistry was used in order to immobilize the
kinases inhibitors SU6668 (Tocris), Purvalanol B (Tocris), and
VI16832 (Evotec) to either ECH-Sepharose or EAH-Sepharose
(GE) beads. Inhibitors were dissolved in coupling buffer
(50/50 sodium phosphate pH 7.0/dimethylformamide) and beads
were prepared according to manufacturer’s recommendations.
Crosslinking was performed in coupling buffer for 24 h
at 4◦C using N-(3-Dimethylaminopropyl)-N-ethylcarbodiimide
hydrochloride (EDC, Sigma-Aldrich) as crosslinker. Beads were
extensively washed with coupling buffer and blocked with
ethanolamine for 24 h.
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Preparation of Cell Lysates and
Enrichment of Protein Kinases by Small
Molecule Affinity Chromatography (SMAC)
Undifferentiated THP-1 cells were harvested by centrifugation
for 5 min and 130 × g at 4◦C and washed twice with phosphate-
buffered saline (PBS). Differentiated and undifferentiated THP-
1 cells were lysed in buffer containing 50 mM HEPES pH 7.5,
2 M NaCl, 1 mM EDTA, 1 mM EGTA, 0.5% (v/v) TritonX-
100, 1 mM PMSF, 50 ng/ml calyculin A, 10 µg/ml leupeptin,
10 µg/ml aprotinin, 10 mM NaF, and 2.5 mM Na3VO4. Cell
lysates were prepared by freeze thawing, followed by sonication.
Cell debris was removed by centrifugation for 30 min at 8700
× g at 4◦C followed by passing through a 0.45 µm cellulose
acetate filter (VWR). Protein concentrations of clarified lysates
were determined by Bradford Assay (BioRad).
Heavy and light SILAC lysates with a total protein content of
50 mg were mixed and applied to affinity columns casted from
500 µl of a 50% bead suspension carrying Purvalanol B and
SU6668 using gravity flow columns (Pierce) and incubated for
1 h at 4◦C on a rotator. The flow through was collected and
applied on a second affinity column casted from 500 µl bead
suspension with immobilized VI16832 and further incubated for
1 h. Columns were washed with 20 column volumes (CV) cell
lysis buffer followed by a wash with 20 CV cell lysis buffer with
150mMNaCl instead of initial 1 MNaCl and a final wash with 20
CV 50 mM HEPES pH 7.5. Bound proteins were eluted with 20
CV prewarmed 0.5% (m/v) SDS and 5mMDTT in 1ml fractions.
Collected fractions were pooled and lyophilized. Experiments
were carried out in three independent biological replicates.
Protein Digest and Phosphopeptide
Enrichment
Lyophilized material was dissolved in water, immediately
followed by addition of 4 volumes of pre-chilled acetone and
incubation at −20◦C overnight. Precipitated proteins were
pelleted by centrifugation (8700 × g, 30 min), dissolved in
denaturing buffer (8 M urea, 20 mM HEPES, pH 8.0), alkylated
by addition of iodoacetamide to a final concentration of 5 mM
for 20 min at room temperature. Samples were separated into
10 gel slices by one-dimensional SDS-PAGE using pre-casted
tris-glycine 4–15% gradient gels (Biorad). Tryptic peptides were
obtained by in-gel digestion followed by peptide extraction. Of
the resulting peptide solutions, 10% were vacuum dried and
stored at −80◦C until mass spectrometry analysis. The residual
90% were vacuum-dried and peptides were dissolved in 1 ml
TiO2-binding buffer (73% (v/v) acetonitrile, 10% (v/v) lactic acid,
2% (v/v) TFA) for phosphopeptide enrichment. 50 µl from a
TiO2-stock solution (30 mg/ml Titansphere TiO2 bulk material
(GL sciences) in 100% acetonitrile) were added and incubated
for 20 min at room temperature. After centrifugation (1000 x
g, 3 min), TiO2-beads were washed 4 times with 80% (v/v)
acetonitrile, 2% (v/v) TFA. Phosphopeptides were sequentially
eluted with 5% (v/v) NH4OH and 30% (v/v) acetonitrile,
vacuum-dried, dissolved in 0.1% (v/v) TFA and purified with C18
StageTips (Thermo Scientific). The eluated phosphopetides were
again vacuum-dried and stored at−80◦C.
Mass Spectrometry Analysis
LC-MS/MS analyses were carried out by an EASY-nLCII HPLC
system directly coupled to a LTQOrbitrap Velos Pro hybrid mass
spectrometer (Thermo Scientific) via a nano-electrospray ion
source. All lyophilized (phospho)peptide samples were dissolved
in 5% (v/v) acetonitrile / 0.1% (v/v) acetic acid and applied to
a 20 cm-long in-house packed C18 (Aeris Peptide 3.6 µm, pore
size 100 Å; Phenomenex) analytical column. Elution of peptides
was carried out with binary linear gradient from 1% (v/v)
acetonitrile/0.1% (v/v) acetic acid to 75% (v/v) acetonitrile/0.1%
(v/v) over a period of 46 min at a flow rate of 300 nl/min. MS
was operated in data-dependent mode, each full MS scan mode
(300 m/z–1700 m/z; resolution 30,000). Ions with charge states of
one or unassigned charge state were excluded for MS/MS scans.
Fragmentation was performed either in the linear ion trap using
collision induced dissociation (CID) for the most 20 intense ions
with an AGC target value of 5 × 103 ions and a normalized
collision energy of 35% or in the Orbitrap mass analyzer of the
most 10 intense ions using higher-energy collisional dissociation
(HCD) with a target value of 5 × 104 ions and 40% normalized
collision energy. Precursor ions selected forMS/MS analysis were
dynamically excluded for repeated fragmentation for a period
of 20 s.
Processing of Data Obtained by Mass
Spectrometry
Obtained .raw files were analyzed using the MaxQuant software
package (version 1.3.0.5) with the integrated Andromeda
search engine (Cox et al., 2011). Files were collectively
searched against the reviewed human proteome deposited
in UniProtKB/Swiss-Prot containing 20,252 protein entries
(UniProt release 2013_04). For peptide and protein identification
and quantification, the following settings were used: The
variable modifications were set to methionine oxidation,
phosphorylation of serine, threonine and tyrosine, and amino-
terminal acetylation. Carbamidomethylation was set as fixed
modification. A maximum of two missed cleavages were allowed.
For peptide identification, a mass tolerance of 0.5 Da and 20 ppm
was allowed for the linear ion trap and theOrbitrapmass analyzer
respectively. The false discovery rate (FDR) was set to 0.01.
Protein quantification was based on razor and unique peptides.
Protein kinases with two independent peptide identifications
including at least one unique peptide were considered. Combined
log2-transformed SILAC ratios were taken from the MaxQuant
output files and considered as reliable when they were based on
values from at least two independent replicates. In rare cases
were a combined SILAC ratio was only calculated based on one
replicate because of the absence of a signal in the unstimulated
or stimulated cell state in the other replicates, this ratio was
only considered if the heavy/light intensities of at least one
additional replicate indicated the same direction of regulation.
The assignment of kinases to groups was according to Manning
et al. (2002).
IPA, KEGG Pathway, and GO Analysis
For the upstream regulator analysis, protein kinases with
corresponding fold changes were imported in the Ingenuity
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Pathway Analysis (IPA) tool (Qiagen) and the core pathway
analysis was performed. Predicted upstream regulators with p <
0.05 and z-scores≤−2 (inactive) and≥2 (active) were considered
and used for network generation.
Kinases with at least two-fold abundance difference between
monocytic and macrophage-like THP-1 cells were subjected to
statistical enrichment analysis of KEGG pathways and GO terms
in Molecular Function (MF) or Biological Processes (BP) with
DAVID Bioinformatics Resources 6.7 (Huang da et al., 2009).
Immunoblotting
Proteins were separated by one-dimensional gel electrophoresis
using precasted 4–15% TRX gradient gels (Bio-Rad) followed
by transfer on PVDF membranes (Merck-Millipore). Blocking
of membranes was carried out for 1.5 h with 5% (m/v) milk in
PBS supplemented with 0.05% (v/v) Tween-20. Membranes were
probed with primary antibodies overnight at 4◦C under gentle
agitation. The following primary antibodies were used: anti-c-
Abl (abcam #ab16903), anti-LIMK1 (CST #3842), anti-ERK1/2
(CST #9102), anti-MEK1/2 (CST #9122), anti-MEK3 (Santa
Cruz #sc-961), anti-MEK4 (Santa Cruz #sc-837), anti-CaMK1
(abcam #ab68234), anti-MerTK (Santa Cruz #sc-365499), anti-
CDK1 (abcam # ab18). Bound primary antibodies were detected
using fluorophore-conjugated secondary antibodies (either
IRDye680RD or IRDye800CW (LI-COR)) and fluorescence
readout was performed using an Odyssey infrared imaging
system (LI-COR).
Phase Contrast Microscopy
Phase contrast micrographs were obtained by using an Olympus
CKX41 fluorescence microscope.
Cell Adhesion Assay
9 × 105 undifferentiated THP-1 cells per well were seeded in
6-well plates (TPP) in RPMI 1640 (Sigma-Aldrich) medium
supplemented with 10% FCS (Sigma). Cells were treated with
0.25, 1 or 5 µM (5Z)-7-Oxozeaenol (5Z, Tocris) or DMSO for
1 h. PMA to a final concentration of 100 nM was added and
cells present in the cell culture supernatant or adhered to the
cell culture plastic were separately counted. Cells present in the
supernatant were collected by centrifugation and resuspended
in RPMI 1640 medium. An aliquot was mixed with trypan
blue solution (LifeTechnologies) and cell viability and cell
count were determined by using and automated cell counter
(Countess, LifeTechnologies). Adhered cells were detached by
incubation with a 5-fold concentrated ready-made trypsin
solution (Biochrom) for 5 min. Trypsinization was quenched by
addition of RPMI 1640 medium following by cell harvest and
counting as described for cells in the supernatant.
Cultivation and Processing of
Staphylococcus aureus for
Infection-Related Experiments
Staphylococcus aureusHG001 (Herbert et al., 2010) was grown in
LB to an optical density (OD540) of 0.5 at 37◦C under agitation.
30ml of the culture were centrifuged for 5 min at 8700 × g and
the resulting cell pellet was washed twice and finally resuspended
in RPMI 1640 medium yielding in a concentration of 5 × 107
cells/ml.
Gentamycin Protection Assay
1.8 × 105 THP-1 monocytes were seeded in a 24-well plate
(TPP) and differentiated as described above. Staphylococcus
aureus HG001 was applied to THP-1 macrophage-like cells at
a multiplicity of infection (MOI) of 25 in conditioned RPMI
1640 medium supplemented with phenol red and 10% FCS. After
various infection durations, medium was removed, cells were
washed with PBS and extracellular staphylococci were killed by
addition of conditioned RPMI 1640medium (supplemented with
phenol red and 10% FCS) containing 100 µg/ml gentamicin
(Sigma-Aldrich) and 20 µg/ml lysosthaphin (Sigma-Aldrich) for
10 min. Cells were washed twice with PBS and subsequently lysed
by addition of 1% (v/v) Triton-X 100 (Roth) in PBS. Intracellular
staphylococci were spread on LB agar plates and colony forming
units (CFU) were determined following incubation for 24 h at
37◦C.
Flow Cytometry
9 × 105 differentiated THP-1 cells were either one-time treated
with 1 µM 5Z or vehicle for 1 h followed by infection with a
GFP-expressing isogenic mutant of S. aureusHG001 pCgfp at an
MOI of 25 for 2 h. Cells were subsequently washed twice with
PBS and non-ingested bacteria were eradicated by lysostaphin
and gentamicin treatment for 10 min with final concentrations
of 20 µg/ml and 100 µg/ml, respectively. Cells were washed
with PBS and detached with trypsin. Digestion was quenched
by addition of RPMI 1640 supplemented with 1% (v/v) FBS.
Cells were pelleted by centrifugation, washed twice with PBS,
resuspended in PBS buffer containing 1% (v/v) FBS and 3.8 mM
sodium azide and finally analyzed for green fluorescence on an
Attune Acoustic Focusing Cytometer (LifeTechnologies).
Quantification of Secreted Chemokines
Triggered by Heat-Inactivated S. aureus
9× 105 differentiated THP-1 cells were seeded in 6-well plates as
described above. Prior of experiments, medium was exchanged
with RPMI 1640 without phenol red and supplemented with
1% FCS. Cells were pretreated with 1 µM 5Z for 1 h prior
addition of heat-inactivated S.aureusHG001. S. aureus cells were
grown and harvested as described above. S.aureus cells were
heat-inactivated for 1 h at 60◦C and resuspended in RPMI
1640 without phenol red and supplemented with 1% FCS and
either 1 µM 5Z or an appropriate amount of DMSO for control
cells. S. aureus was applied to THP-1 cells at a MOI of 25.
Following various incubation times, cell culture supernatants
were harvested, passed through a 0.2 µm nitrocellulose filter
(VWR) and stored at −80◦C. Quantification of a selected set of
chemokines from cell culture supernatants after 6 h and 48 h
following addition of heat-inactivated S. aureus was performed
using a custom ELISA Array kit (Qiagen) according to the
manufacturer’s recommendations. The kinetics of secretion for
IL-8, GROa, MIP-1a and MIP-1b were analyzed using ELISA kits
(Qiagen) according to the instruction by the manufacturer.
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RESULTS AND DISCUSSION
Monocyte-to-Macrophage Differentiation
is Accompanied by Major Restructuring of
the Kinome, Increase of the General
Kinome Phosphorylation Status and
Changes in the Basal Activation of
Individual Kinases
Cellular signaling mediated by protein kinases regulates virtually
any cellular function, showing the vital role of this enzyme
class for cell physiology. Despite their striking impact, protein
kinases are commonly low abundant proteins and kinome
characterization requires reduction of sample complexity
i.e., kinase enrichment when using mass-spectrometry based
proteomic strategies. Our approach to perform a comparative
and system-wide kinome profiling of the human model cell
line THP-1 before and after PMA-mediated induction of
differentiation into the macrophage-like state is depicted in
Figure 1A. We used the ATP-competitive small molecule
protein kinase inhibitors Purvalanol B, SU6668 and VI16832
immobilized to sepharose beads for protein kinase family-
specific pre-enrichment in combination with stable isotope
labeling of amino acids in cell culture (SILAC). The inhibitors
were previously demonstrated to be efficient kinase purification
tools with binding of distinct but overlapping sets of protein
FIGURE 1 | (A) Experimental outline for comparative kinome profiling of undifferentiated (monocytic) and differentiated (macrophage-like) THP-1 cells. Cells were
metabolically labeled (SILAC) and differentiation was induced by addition of phorbol-12-myristate 13-acetate (PMA) for 3 days followed by a period of resting for 1 day
in PMA-free medium. Cells were lysed and lysates from both THP-1 differentiation stages were combined equally. Small molecule affinity chromatography (SMAC)
utilizing broadband kinase inhibitors SU6668, Purvalanol B and VI16832 was used for protein kinase purification. Eluted kinases were lyophilized, re-hydrated and
precipitated by acetone. Gel fractionated proteins were digested by trypsin and resulting peptides were extracted. Peptides were separated whereas 90% were used
for TiO2-based phosphopeptide enrichment prior to mass spectrometric analysis. The remainder was directly analyzed by mass spectrometry for quantification of
protein kinases. (B) Phylogenetic kinase relationship (Manning et al., 2002). Protein kinases identified and quantified in our study are indicated as gray and black
circles, respectively. (C) Assignment of log2-SILAC abundance ratios of quantified protein kinases to their corresponding kinase groups.
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kinases allowing a broad coverage of the kinome by their
combined usage (Wissing et al., 2007; Daub et al., 2008;
Oppermann et al., 2009; Zhang et al., 2013). In addition, kinase
binding to mixed-inhibitor beads has recently been shown
to be largely independent of kinase activity (Ruprecht et al.,
2015). The enriched protein kinases were analyzed by liquid
chromatography–mass spectrometry (LC-MS/MS) at the level
of protein expression and site-specific protein phosphorylation,
after applying an additional phosphopeptide enrichment.
Our workflow resulted in the identification of 199 protein
kinases from at least two independent peptide sequences
(Supplemental Table 1). Of these, 163 kinases fulfilled the
criteria for a quantitative comparison between the monocytic
and macrophage-like state (Figure 1B). Twenty-six protein
kinases were increased at the protein level in macrophage-
like cells, whereas 60 were observed with significantly higher
protein amounts in the monocytic state (fold-change cut-
off of 2.0). The observed changes at the level of protein
affected kinases of nearly all groups of the human protein
kinase-family including mitogen-activated protein kinases such
as MAPK13, MAP2K1, MAP2K3, MAP2K4, MAP3K7, and
MAP3K2, calcium/calmodulin-activated protein kinases e.g.,
CAMK1, CAMKK1, CAMK2A and CAMK2B, and Src-family
kinases (FGR, HCK, SRC, YES; Figure 1C, Supplemental Table
1). The SILAC ratios of selected protein kinases with unchanged
or differential expression were validated by western blots using
independent protein extracts (Supplemental Figure 1).
Within the identified kinome, we mapped and quantified 311
phosphorylation sites (222 phosphoserine, 55 phosphothreonine,
and 34 phosphotyrosine sites) in 118 protein kinases
(Supplemental Table 1). Importantly, most sites have so far
only a comparatively low number of records in which the
modification was determined using site-specific methods or by
proteomic discovery-mode mass spectrometry indicating that
the enrichment strategy increased the sensitivity of detection
of modified kinase-derived peptides with mass spectrometry
(Hornbeck et al., 2012). For example, at Ser212 of the non-
receptor tyrosine kinase Src, we mapped a novel phosphorylation
site, located within its SH2-domain suggesting a potential
regulatory role in the interaction with tyrosine phosphorylated
Src interactors (Figures 2A,B). Two hundred twenty-three
phosphorylation sites were considered as significantly changed
following PMA-mediated differentiation when we applied
the same two-fold cut-off as for the differential protein
expression. Changes in phosphorylations indicated an overall
increased phosphorylation status in macrophage-like cells with
142 phosphosites found increased following differentiation
compared to 81 phosphosites found decreased following
differentiation (Supplemental Table 1).
To assess whether the observed changes in kinase
phosphorylation directly correlated with changes at the
kinase expression level, we normalized the SILAC-based
peptide-phosphorylation ratios of 245 phosphosites to their
corresponding changes in protein expression (Figure 2C).
More than half of the phosphosites still showed changes of
at least two-fold after normalization proving higher or lower
phosphorylation that exceeds the changes at the level of
FIGURE 2 | (A) Annotated MS/MS spectrum of the peptide from the tyrosine
kinase Src spanning amino acids 209–220 with phosphorylation at Ser212.
(B) Protein domain organization of Src indicating the pSer212 position in the
SH2 domain. The difference in the level of phosphorylation of Ser212
between macrophage-like vs. monocytic THP-1 cells is indicated (relative
change) and normalized to changes in the Src protein amount (absolute
change). (C) Correlation of quantified phosphorylation sites with
corresponding protein kinase abundance. The solid diagonal line indicates
perfect correlation between changes in the amount of phosphorylations and
changes in the corresponding protein kinase amounts, i.e., differences in
phosphorylations are only attributed to changes in the protein amounts. The
dashed lines indicate two-fold changes of phosphorylations (in both
directions), i.e., changes in phosphorylations are not exclusively attributed to
changes in protein abundance. Dots highlighted in orange indicate increased
phosphorylation in macrophages whereas blue dots indicate increased
phosphorylation in monocytes. Red-rimmed dots highlight kinase
phosphorylation sites implicated in the induction of kinase activity.
protein expression. In detail, 100 phosphosites in 52 kinases
appeared as truly upregulated in the macrophage-like state
and 38 phosphosites in 28 kinases were found as upregulated
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in monocytic THP-1 cells, further supporting a general trend
toward a higher phosphorylation status following differentiation
(Supplemental Table 1, Figure 2C). A comparison with the
PhosphoSitePlus database (Hornbeck et al., 2012) revealed
a potential functional implication for 21 of the regulated
phosphosites (Supplemental Table 1). For example, in the
macrophage-like cells phosphorylated Tyr687 in the receptor
tyrosine kinase RET (17.3-fold up) recruits the protein-tyrosine
phosphatase SHP2 and thereby contributes to activation of the
PI3K/AKT pathway (Perrinjaquet et al., 2010), the monitored
sites in FYN (Ser21; 9.8-fold), Src (Ser17; 2.5-fold), MAPK3
(ERK1, pT202; 4.6-fold), and MAPK1 (ERK2, pY187; 2.4-fold)
are direct inducers of kinase activity (Payne et al., 1991; Schmitt
and Stork, 2002; Yeo et al., 2011) suggesting an increased basal
activity of these kinases, their upstream modulators as well
as associated downstream pathways after cell differentiation
(Figure 2C). This effect is likely independent of PMA stimulation
and indeed relevant for the differentiation status, because PMA
was removed and cells were rested in PMA-free media for 1 day
before analysis.
In summary, our results show that monocyte to macrophage
differentiation is accompanied by major rearrangements of the
kinome, at the level of protein kinase expression as well as at the
level of kinase phosphorylation.
Identification of Upstream Regulators
Associated to Kinome Changes in
Monocyte Differentiation
To predict potential upstream regulators implicated in
switching the monocyte/macrophage kinome at the level of
gene expression, we performed an upstream regulator analysis
of the quantified protein kinases with the Ingenuity Pathway
Analysis (IPA) software. Twelve transcriptional upstream
regulators with partly mutual regulation and overlapping
downstream targets could be highlighted that are likely critical
in the differentiation process (p ≤ 0.05, Figures 3A,B). Out of
these, eight are predicted to be active (z-score ≥ 2) and four
as inhibited (z-score ≤ −2). Naturally, PMA used as trigger
for THP-1 cell differentiation was found among the top active
regulators with a direct correlation to increased amounts of
many protein kinases including MAP2K1, IRAK1, SRC, and
CDK1. Among the group of transcription factors, MYC and
TBX2 were predicted as inhibited with an overlap in the assigned
depletion of kinases such as AURKA, AURKB, PLK1, and
CDK1. Moreover, the transcriptional regulator TP53 (p53) was
assigned to be active and was predicted to be involved in the
transcriptional regulation of kinases including repression of
DYRK1A (Zhang et al., 2011b), WEE1 (Lezina et al., 2013),
PKC-alpha (Zhan et al., 2005), and induction of SGK1 (You
et al., 2004). However, since expression of functional p53
has not been demonstrated for THP-1 cells so far (Sugimoto
et al., 1992; Durland-Busbice and Reisman, 2002), this finding
might be indicative for activation of a transcriptional regulator
with a target gene pattern similar to p53. Finally, a potential
significant implication for three regulatory micro-RNAs in
the process of THP-1 differentiation was found, namely
FIGURE 3 | (A) Predicted upstream-regulators implicated in kinase expression
changes. Bar chart includes activation z-score and p-value derived from IPA.
Z-scores ≤ −2 indicate inactivity (green area), whereas z-score ≥ 2 indicate
active regulators (red area). (B) Upstream-regulator network as predicted by
IPA. The outer circle is composed of quantified protein kinases, which are
color-coded according to their corresponding SILAC ratios. The inner circle is
composed of predicted upstream-regulators that might be involved in the
regulation of kinase expression. The upstream regulators are colored according
to (A). Solid lines indicate direct molecular interaction, whereas dashed lines
indicate indirect molecular interaction. Coloration of lines in orange, blue, gray,
and purple indicates the predicted relationship of upstream-regulators with
downstream protein kinases as activation, inactivation, no prediction and
inconsistency with the state of downstream molecule, respectively.
mir-124-3p, mir-15, and let-7, with the latter two involved in
inhibition of transcripts of several cell-cycle-associated kinases
including CHECK1, CDK1, CDK6, as well as AURKA, and
AURKB.
Most of the suggested transcriptional regulators were not
highlighted in a global transcriptome study of THP-1 cell
differentiation (Consortium et al., 2009) suggesting a potential
more significant relevance for kinase-coding genes that should
be followed-up in future studies. However, MYC and p53,
e.g., are frequently deregulated in cancer and THP-1 cells
are derived from a patient with acute monocytic leukemia
(Tsuchiya et al., 1980). Thus, translation of the results to primary
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human monocytes has to be done with care. Moreover, besides
transcription, protein synthesis rates were recently determined as
additional primary drivers for global protein expression changes
in differentiating THP-1 cells (Kristensen et al., 2013).
THP-1 Macrophages are Characterized by
Kinases that are Related to
Calcium/Calmodulin Signaling and Actin
Dynamics
Protein kinases increased in the macrophage state point to a
prominent role of these kinases in the regulation of macrophage-
specific differentiation and function and are predictors of
relevant intracellular signaling pathways and downstream effects.
We identified LIMK1, TNIK, MERTK, FGR, ACVR1, and STK10
within the top 15 protein kinases with highest protein ratios in
macrophages vs. monocytes (12.5-fold to 3.1-fold, Supplemental
Figure 1). Remarkably, the majority of these kinases collectively
share functional implications in signaling pathways of actin
dynamics. LIMK1 is the regulatory kinase of the actin-binding
factors cofilin and destrin. The actin-depolymerizing factor
(ADF)/cofilin family of proteins is essential for the dynamic
changes in the actin cytoskeleton that occur during cell
locomotion or other processes including phagocytosis (Arber
et al., 1998; Amano et al., 2001; Bierne et al., 2001; Matsui
et al., 2002). TRAF2 and NCK-interacting protein kinase TNIK
regulates the c-Jun N-terminal kinase pathways, which is an
essential and specific activator of Wnt target genes and regulates
actin rearrangements and cell spreading (Fu et al., 1999; Taira
et al., 2004; Mahmoudi et al., 2009). The tyrosine kinase Mer
belongs to the unique family of TAM - Tyro3, Axl, and Mer—
receptors which together with their ligands Gas6 and Protein
S are essential for the efficient phagocytosis of apoptotic cells
and debris and act as pleiotropic inhibitors of the innate
inflammatory response to pathogens—an important prevention
mechanism of chronic inflammation and autoimmunity (Scott
et al., 2001; Rothlin et al., 2007). STK10/LOK has recently been
demonstrated to co-localize and phosphorylate ERM (ezrin-
radixin-moesin) proteins in lymphocytes, which crosslink actin
filaments with plasma membranes, and is thereby important in
the regulation of cell shape and migration (Belkina et al., 2009).
In addition to the observed increase in protein expression, several
phosphorylation sites in the aforementioned kinases showed
regulation independent of the changes in protein expression
(Supplemental Table 1). Whereas a single upregulated site was
identified in TNIK and Fgr, STK10 was found with four up- and
three downregulated sites. The upstream kinases or implication
of these sites in kinase function, however, is so far unknown.
Collectively, the identified kinases indicate an increased
capacity in the regulation of the actin cytoskeleton in
macrophages, which is important in the control of immune
responses including motility and chemotaxis, phagocytosis,
and antigen presentation (May and Machesky, 2001; Van
Haastert and Devreotes, 2004; Stradal et al., 2006). Severe
immunodeficiency has been linked to mutations that affect
cytoskeletal dynamics in macrophages and many macrophage-
infecting pathogens manipulate actin remodeling to support
their intracellular lifestyle (Linder et al., 2000; Krachler et al.,
2011; Roy et al., 2014).
To extend our study, we evaluated the macrophage-
specific kinome by performing bioinformatic enrichment
analysis including gene ontology (GO) classification and Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathway analysis
(Dennis et al., 2003; Supplemental Table 2). This approach
naturally revealed the overrepresentation of kinases in individual
GO-molecular functions, -biological processes and KEGG
pathways. Consequently, we became aware of the significant
enrichment of protein kinases (Benjamini-Hochberg corrected p
≤ 0.001) in terms that are associated with calmodulin-dependent
protein kinase activity (GO:0004683) as well as Toll-like receptor
and associated MAPK signaling (GO:0000165, hsa04620). The
association of our data set to calcium/calmodulin-dependent
protein kinase activity is due to the increased expression of
CAMK1 (3.3-fold), CAMKK1 (2.8-fold), and CAMK2A/2B
(4.9-fold/7.3-fold) when the macrophage-like state is compared
to the monocytic precursor. In addition, several phosphosites
were detected with changes in calmodulin-dependent protein
kinases (Supplemental Table 2). Interestingly, CAMKK2, which
was found with decreased expression, showed upregulated
phosphorylation at Ser495 and Ser511 (4.8 and 4.0-fold)
indicating increased upstream phosphorylation activity, for the
latter site likely by the death-associated protein kinase (DAPK)
(Schumacher et al., 2004). Components of calcium/calmodulin-
dependent protein kinase cascades CAMKs operate in a variety of
cellular functions including regulation of transcription activators,
cell cycle, hormone production, cell differentiation, actin
filament organization, and neurite outgrowth. In macrophages,
CAMK1 has recently been demonstrated to be integral to the
inflammatory response to sepsis (Zhang et al., 2011a) and
CAMK2 has a role in antimicrobial activities via regulation of
phagosome maturation (Malik et al., 2001) and is involved in
the activation of the NLRP3 inflammasome, leading to cytokine
production and the activation of the immune system (Okada
et al., 2014). The observed overrepresentation of kinases in
Toll-like receptor signaling was mainly based on MAPK cascade
kinases [e.g., MAPK13 (12.5-fold), MAP3K7 (3.3-fold), MAP2K4
(2.6-fold), and MAP3K2 (2.3-fold)] reflecting their important
role for the transduction of pathogen-associated signals to
adequate immune responses in macrophages. The MAPK
signaling-associated kinases, however, are shared by many other
pathways. Interestingly, whereas the essential upstream kinases
for TLR-signaling interleukin 1 receptor associated kinases IRAK
1 and 4 were below our two-fold significance cut-off, the negative
regulator IRAK3 is 4.7-fold decreased in macrophage-like cells.
THP-1 Monocytes Show Increased
Expression of Kinases Associated with Cell
Cycle and DNA Repair
We then addressed which kinases are at higher protein levels
in the monocyte state, i.e., before PMA treatment of THP-
1 cells. Functional annotation analyses of the monocyte-
associated kinome revealed an overrepresentation of kinases
within biological processes and molecular functions related to
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cyclin-dependent protein kinase activity, cell cycle, MAP kinases
and magnesium ion binding (Supplemental Table 2, Figure 4A).
This implicates a pronounced requirement for protein kinases
in the control of the corresponding signaling pathways in the
monocytic cell state. In fact, the loss of proliferative activity
of terminally differentiated macrophages is a hallmark of THP-
1 differentiation (Auwerx, 1991). In our hands, monocyte-to-
macrophage differentiation is accompanied by a pronounced
decrease in the abundance of key regulatory kinases implicated
in entry and progression through different cell cycle phases
including the cyclin-dependent kinases CDK1, CDK2, CDK6,
AURKA, AURKB, and PLK1 as well as the checkpoint kinases
CHEK1 and CHEK2 (Supplemental Table 1, Figures 4A,B).
In addition to the cell cycle-related kinases, several kinases
involved in regulation of DNA repair mechanisms were found in
significant higher amounts in the monocytic state, among them
the cyclin-dependent kinase CDK9 as well as DNA-dependent
protein kinase catalytic subunit PRKDC (Yu et al., 2010;
Jiang et al., 2015). Several phosphosites with known functional
implications, mainly in enzymatic activity, were found to be
regulated in the cell cycle- and DNA repair-associated kinases
[CDK2 Tyr15 and Thr160 (5.5-fold and 3.1-fold, respectively,
down), CDK9 Ser464 (2.5-fold), CHEK1 Ser286 (2.2-fold) and
CDK1 Tyr15 (2.1-fold)]. Phosphorylation of Thr160 in CDK2,
e.g., is critical in inducing kinase activity that promotes G1/S
transition and progression through S phase following binding to
Cyclin E and Cyclin A respectively (Girard et al., 1991; Gu et al.,
1992; Ohtsubo et al., 1995).
Our data suggest that the consequent stop of proliferation
following PMA-triggered THP-1 monocyte differentiation
involves depletion of cell cycle-controlling kinases in the
macrophage-like cell in comparison to the monocyte precursor.
The decreased relative phosphorylation level in macrophages
additionally indicates downregulated upstream signaling that
likely advances the proliferation arrest. Since THP-1 cells are
derived from a patient with acute monocytic leukemia (Tsuchiya
et al., 1980), the increased expression of cell cycle and DNA
repair-associated protein kinases can be most likely linked to
their oncogenic profile.
Similar to the macrophage-like characteristic kinome, we
again observed an overrepresentation of kinases from MAP
signaling cascades in the monocytic state, which is based on the
higher protein level of a different set of members of this group
including TAOK3 and MAP3K1.
THP-1 Differentiation Results in Rewiring
of MAPK Signaling Networks
The noticeable overrepresentation of different sets of MAP
kinases and upstream MAPK kinases prompted us to a
more detailed inspection. Notably, at least 30 kinases directly
associated with MAP kinase signaling cascades were identified
by our approach and many showed differing amounts in
THP-1 monocytes vs. macrophages (Figure 5). The diverging
protein level of such a high number of MAP kinases
and associates signifies the key position of this network in
monocyte/macrophage differentiation and function. Differences
in protein amounts of at least two-fold were observed for
two MAP kinases, two MAP kinase activated protein kinases
(MAPKAPKs) as well as 11 upstream MAP kinases spanning
MAP4Ks, MAP3Ks, and MAP2Ks. The latter are involved in
activation of MAPKs including ERK, p38alpha and JNK or
NF-kappaB signaling via phosphorylation of IkappaB kinases
(Matsuda et al., 1992; Yang et al., 1997; Wang et al., 2002). The
MAPKs MAPK3/ERK1 and MAPK1/ERK2, MAPK8/JNK1, and
MAPK9/JNK2 as well as MAPK14/p38alpha were observed at
equal protein amounts and in fact only MAPK13/p38delta was
found in approximately 12-fold higher amounts in macrophage-
like cells, whereas ERK5 was 6.1-fold increased in monocytic
THP-1 cells (Figure 5, Supplemental Table 1). However,
corresponding phosphorylation profiles suggest increased basal
activity for ERK1/2 (see above) but also increased activity for
ERK-activated ribosomal s6 kinases (RSKs) in macrophages
(Figure 5). Aside from several upstream MAPK kinases with
increased expression levels (GCK, MEKK1, TAOK1/2/3, PAK4,
ERK5), the mitogen- and stress-activated protein kinases MSK 1
and 2 were found in pronounced higher levels in unstimulated
monocytes suggesting a more prominent function in the
monocytic cell state.
Our results indicate that the differentiation of macrophage
from their monocytic progenitors is accompanied by extensive
rewiring of the MAPK-signaling cascades. Obviously, MAP
signaling is not organized as one-way connections from one
cell surface receptor via strictly separated kinase cascades to
specific responsive elements but forms highly interconnected
networks with overlapping hubs. For instance, p38-alpha-related
signaling with downstream MSK1/2 seems more prevalent in
THP-1 monocytes, whereas ERK/RSK-mediated signaling is
likely more associated with the macrophage-like cell state. RSKs
are multifunctional ERK effectors that regulate diverse cellular
processes via cooperative regulation of many substrates including
activation of the transcription factor FOS (Hauge and Frodin,
2006). MSK, on the other hand, is mainly known for its
role in gene expression by phosphorylation of transcription
factors such as CREB (Hauge and Frodin, 2006). In agreement
with our kinase data, FOS and CREB activity is increased
and decreased, respectively, following THP-1 differentiation
(Consortium et al., 2009). Our data thus shed new light on how an
adapted phenotype and altered signal responsiveness following
differentiation can be achieved besides changing the expression of
cell surface receptors or transcription factors but by fine-tuning
the expression and/or activation of intermediate signaling nodes.
MAP3K7 (TAK1) is a Central Signaling Hub
in Bacterial Killing, Chemokine Production,
and Differentiation Activity
As a result of PMA-induced transition from the monocyte to
the macrophage state, several kinases associated with the MAPK
signaling network includingMAP3K2 and 7 as well asMAP2K1,3
and 4, and MAPK13 were more than two-fold increased. We
selected the protein kinase MAP3K7 (Transforming growth
factor β-activated kinase, TAK1) for functional analysis based on
its up-stream activator position of MAP2K3/4 and MAPK13 as
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FIGURE 4 | (A) Selected significantly enriched GO terms or KEGG pathways of protein kinases enriched either in THP-1 macrophages or monocytes. Bars indicate
Benjamini-Hochberg corrected p-values of ≤0.001 (dotted line). Denoted numbers indicate the number of protein kinases assigned to the respective term or pathway.
Protein kinase names are provided on the right and colored according to their affiliation to the macrophage-like (orange) or monocytic (blue) cell state. (B) Schematic
representation of the cell cycle with important protein kinases required for cell cycle progression and mitosis. Numbers indicate determined log2-SILAC ratios of
protein kinases and phosphorylation sites with regulatory function.
well as the possibility to inhibit TAK1 activity by pharmacological
intervention. Activation of TAK1 is triggered by various stimuli,
including cytokines as well as ligands of Toll-like-, B cell- and
T cell receptors, and a key signaling component of NF-κB and
MAPK signaling pathways that exerts cell type-specific functions
(Ninomiya-Tsuji et al., 1999; Wang et al., 2001; Wan et al., 2006;
Schuman et al., 2009).
From our kinomic data, we conclude TAK1 to be more
active in macrophage-like cells as indicated by the increased
phosphorylation of the down-stream targets MAPK1/3.
Moreover, phosphorylation of MAPK1/3 (pT202/pY204)
and the additional downstream targets MAPK14 (p38alpha;
pT180pY182) and HDAC4 at S264 (Dequiedt et al., 2006) in
short-term PMA-stimulated cells was abolished when TAK1
activity was abrogated by pre-treatment with the TAK1-selective
inhibitor (5Z)-7-Oxozeaenol (5Z) (Ninomiya-Tsuji et al., 2003;
Figure 6A).
To address the role of TAK1 in regulation of macrophage-
associated functions, we inhibited TAK1 in differentiated THP-1
cells with a one-time treatment of 5Z and screened for effects
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FIGURE 5 | MAP kinase network with identified protein kinases (ellipses) or phosphorylation sites (attached dots). Log2-SILAC ratios of macrophage-like
and monocytic THP-1 cells are provided as color scheme. Phosphorylation sites with known functional implications are highlighted with a red border. Lines indicate
kinase-substrate relationships obtained from the literature and online resources.
on the efficacy in bacterial killing as well as the production
of chemokines. First, we performed a gentamicin protection
assay to compare the number of recovered staphylococci from
infected THP-1 macrophages with and without inhibition of
the TAK1 activity. Already 15 min. post infection, a prominent
decrease in extracted vital S. aureus colony forming units derived
from TAK1-inhibited THP-1 macrophages became apparent
(Figure 6B). This finding of decreased surviving bacteria became
significant during the course of the infection reaching a
maximum of 40% 105 min post infection. Considering that
recovery of S. aureus cells was performed only from attached
THP-1 cells, we counted THP-1 cells present in the supernatant
of the infection experiment to exclude that the observed strong
drop in intracellular S. aureus is due to TAK1 inhibition-
mediated increase in macrophage detachment from the cell
culture surface (Figure 6C). TAK1 inhibition did not lead to
significant differences in the number of cells in the suspension
compared to non-TAK1-inhibited macrophages. Moreover, flow
cytometric analyses with GFP-expressing S. aureus revealed
a comparable bacterial load independent of TAK1 inhibition
(Figure 6D) indicating that the efficiency of THP-1 macrophages
to internalize bacteria was not altered by TAK1 activity.
Collectively, the results of the infection assays thus point
to a critical link of TAK1 signaling to phagocytic killing of
intracellular microbes.
Next, to characterize the importance of TAK1 activity in
chemokine production of macrophages, we pre-screened the
secretion of an array of 12 chemokines following interaction with
heat-inactivated S. aureus using ELISAs (Supplemental Figure
2). For seven chemokines we were able to detect a meaningful
signal. While TGF-beta and MDC were secreted approximately
in equal amounts in control cells and S. aureus-treated cells with
and without 5Z, RANTES showed pronounced higher secretion
in response to heat-inactivated S. aureus but no reduction with
accompanying TAK1 inhibition. In contrast, we observed TAK1-
dependent secretion of IL-8, MIP-1A, MIP-1B, and GROa which
lead us to investigate kinetics of their secretion (Figure 6E).
Strikingly, inhibition of TAK1 activity abolished the secretion
of all four chemokines in response to S. aureus. The results
thus indicate a pivotal role of TAK1 in the pathogen-induced
production and/or release of specific chemokines following
macrophage interaction with S. aureus.
TAK1 has recently been demonstrated to be essential for
osteoclast differentiation (Lamothe et al., 2013). Eventually, we
therefore asked if TAK1 has an implication in the differentiation
of macrophages in the THP-1 background. For this purpose,
monocytic THP-1 cells were one-time treated with 5Z prior
to stimulation with PMA and monitored for indicators of
differentiation including the ability to adhere to surfaces and
to form characteristic morphological features. Inhibition of
TAK1 activity in THP-1 monocytes by 5Z prevented typical
cell elongation and formation of pseudopodia (Figure 6F),
significantly reduced cellular adherence efficacy to the surface
of cell culture material after PMA stimulation (Figure 6G) and
caused abrogation of PMA-induced arrest in cell proliferation
(Supplemental Figure 3). Cell viability, on the other hand, was
not altered by TAK1 inhibition (Supplemental Figure 3).
Taken together, the obtained results highlight TAK1 as
a central signaling hub involved in macrophage-associated
bacterial killing and pathogen-induced chemokine production
and development of a macrophage-like phenotype. Its character
as central signaling component is most likely mediated through
its well-known role in downstream activation of ERK, JNK, p38,
and NF-kappaB signaling pathways (Tang et al., 2008; Lamothe
et al., 2012; Mihaly et al., 2014). The observed prevention
of PMA-induced phosphorylation of direct and indirect TAK1
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FIGURE 6 | (A) Western blot analysis of known downstream targets of TAK1. THP-1 monocytes were treated with 1 µM 5Z or vehicle for 1 h followed by stimulation
with PMA for the indicated time periods. (B) Percentage of recovered colony forming units (CFU) of S. aureus infected THP-1 cells pretreated with 1 µM 5Z normalized
to untreated THP-1 cells. Data is represented as mean ± S.D. (n = 3). (C) Count of THP-1 cells present in the cell culture supernatant in uninfected controls, following
infection with S. aureus either pretreated with 1 µM 5Z or not, and uninfected controls pretreated with 1 µM 5Z. Data is represented as mean ± S.D. (n = 3). (D)
Fluorescence distribution of PMA-differentiated adherent THP-1 cells infected with GFP-expressing S. aureus either pretreated with 1 µM 5Z or not and uninfected
control cells as analyzed by flow cytometry. (E) ELISA-based quantification of secreted chemokines IL-8, MIP-1a, MIP-1b, and GROa following interaction with heat-
inactivated S. aureus either pretreated with 1 µM 5Z or not compared to control THP-1 cells. (F) Light micrographs of THP-1 cells 3 days post PMA stimulation either
with or without pretreatment with 1 µM 5Z. (G) Cell counts of THP-1 cells present either in the cell culture supernatant fraction (upper chart) or adhered fraction (lower
chart) monitored over 72 h post PMA treatment in the absence and presence of different concentrations of 5Z. Data is represented as mean ± S.D. (n = 3). Statistical
analysis of variance was performed by two-way ANOVA with Bonferroni post tests. *p < 0.05, **p < 0.01, ****p < 0.0001.
downstream targets and the accompanying differentiation defect
in the presence of 5Z implicates a functional cooperation of TAK1
and PKC, because PMA is an inducer of PKC activity which
is essential for PMA-triggered THP-1 differentiation (Bazzi and
Nelsestuen, 1989; Schwende et al., 1996). A PKC-dependent
activation pathway of TAK1 has been described in lymphocytes.
B cell or T cell receptor stimulation induces activation of
protein kinase C-isoforms, which leads to phosphorylation of
CARD11/CARMA1. A complex of CARD11/CARMA1, BCL10,
andMALT1 then interacts with TRAF6 ubiquitin ligase, which in
turn activates TAK1 via polyubiquitination of the TAK1 protein
kinase complex composed of its binding partners, TAB1, TAB2,
or TAB3 (Sato et al., 2005; Sommer et al., 2005; Schuman et al.,
2009).
We also demonstrated stimulation of chemokines by the
human pathogen S. aureus with a dependency on TAK1
activity. Our results indicate the activation of TAK1 via toll-
like receptors that recognize S. aureus-associated molecular
patterns. Different from PMA, TLRs activate TAK1 via MyD88
and recruitment of IRAK1 and IRAK4, which in turn activate
the TRAF6 ubiquitin ligase leading to TAK1 activation (Shim
et al., 2005).TLR2 has been shown to be the key sensor for
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recognition of S. aureus (Iwaki et al., 2002) suggesting a direct
function in TAK1 activation. This, however, has not yet been
experimentally demonstrated. Eventually, TAK1 inhibition let
to an improved intracellular killing of S. aureus. This suggests
subcellular alterations that increase bactericidal activity and a
potential implication of reactive oxygen species (ROS) such as
hydrogen peroxide. Accumulation of ROS in a non-functional
TAK1 background has recently been demonstrated in different
models including murine keratinocytes and intestinal epithelium
as well as cells of the myeloid lineage (Omori et al., 2008, 2012;
Wang et al., 2015). Increased ROS levels within phagosomes of
TAK1-inhibited THP-1 macrophages could not be demonstrated
thus far. From our experimental setup it cannot be excluded that
TAK1 plays a similar role in stimulated monocytes. Moreover,
since TAK1 is at the crossroad of multiple signaling pathways
additional processes in phagosomal maturation or clearance
might be affected and need to be considered in future studies
addressing the specific role of TAK1-signaling in phagocytic
destruction of microbes. Finally, although 5Z is a highly potent
TAK1 inhibitor and selective over a set of other kinases within
the MAP3K pathway, off-targets cannot be fully excluded (Kilty
et al., 2013).
CONCLUSION
Human monocytic THP-1 cells differentiate into macrophage-
like cells with increased adherence and loss of proliferative
activity by PMA treatment. We found that half of the kinome
was altered at the level of protein expression and even 71%
of all covered kinase phosphorylation sites were significantly
changed at the level of protein phosphorylation showing a
massive rearrangement of the macrophage-specific kinome in
comparison to its monocytic precursor counterpart. Our analysis
of the kinomic data furthermore highlights cell state-specific
kinase subsets such as cyclin-dependent kinases associated
with cell cycle control at higher levels in THP-1-monocytes
and calmodulin-dependent kinases and kinases involved in
proinflammatory signaling more expressed in macrophages.
Our kinomic approach eventually revealed protein kinase
MAP3K7/TAK1 as a master regulator for macrophage-associated
functions. Application of functional assays allowed us to identify
that TAK1 kinase activity is essentially associated with the PMA-
induced arrest in cell proliferation and cellular differentiation.
Moreover, we could demonstrate that TAK1 activity is associated
with bacterial killing and is essential for the secretion of several
chemokines including IL-8 as the primary inducer of chemotaxis
in neutrophils and other granulocytes. In conclusion, we suggest
the kinome rearrangement and theMAPK rewiring as a hallmark
of monocyte-to-macrophage differentiation and we consider
protein kinase TAK1 as a key signaling hub and master regulator
for macrophage function. For future research applications, we
anticipate that focus to TAK1 and its signaling network may
result in the understanding of macrophage-associated diseases
and may also serve as starting point for novel therapeutic targets.
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